| __timestamp | CRISPR Therapeutics AG | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5114000 | 1213000 |
| Thursday, January 1, 2015 | 13403000 | 3425000 |
| Friday, January 1, 2016 | 31056000 | 6311000 |
| Sunday, January 1, 2017 | 35845000 | 9518000 |
| Monday, January 1, 2018 | 48294000 | 28080000 |
| Tuesday, January 1, 2019 | 63488000 | 36550000 |
| Wednesday, January 1, 2020 | 88208000 | 46125000 |
| Friday, January 1, 2021 | 102802000 | 68486000 |
| Saturday, January 1, 2022 | 102464000 | 92032000 |
| Sunday, January 1, 2023 | 76162000 | 117532000 |
| Monday, January 1, 2024 | 72977000 |
Data in motion
In the competitive world of biotechnology, managing operational expenses is crucial for sustaining growth and innovation. This analysis compares the Selling, General, and Administrative (SG&A) expenses of CRISPR Therapeutics AG and Rhythm Pharmaceuticals, Inc. over a decade, from 2014 to 2023.
CRISPR Therapeutics AG, a pioneer in gene-editing technology, saw its SG&A expenses grow by approximately 1,400% from 2014 to 2021, peaking in 2021. However, a notable decline of around 26% was observed in 2023, indicating a strategic shift towards cost efficiency.
Conversely, Rhythm Pharmaceuticals, Inc., focused on rare genetic disorders, experienced a staggering 9,600% increase in SG&A expenses over the same period, with a consistent upward trend culminating in 2023. This suggests an aggressive expansion strategy.
Understanding these trends provides valuable insights into each company's operational strategies and market positioning.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Rhythm Pharmaceuticals, Inc.
Biogen Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: SG&A Expense Trends
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or CRISPR Therapeutics AG
Alpine Immune Sciences, Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Amneal Pharmaceuticals, Inc. or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? CRISPR Therapeutics AG or Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: CRISPR Therapeutics AG vs Wave Life Sciences Ltd. Trends and Insights
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and Galapagos NV
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or Xencor, Inc.